Dr. Allison Lorna Agwu, MD

Dr. Agwu practices at Jhu - Oncology in Baltimore, Maryland.

Dr. Agwu's NPI, 1598802027, was assigned on February 1, 2007. Dr. Agwu graduated from University of Maryland School of Medicine - Baltimore in 1999. Dr. Agwu holds Maryland license D66215.

Dr. Agwu's primary practice is Jhu - Oncology, at 401 N Broadway St, Baltimore, MD 21287 in Baltimore City. The practice phone is (410) 933-7400.

Dr. Agwu's primary practice is Jhu - Oncology in Baltimore, Maryland. Dr. Agwu is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Agwu to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agwu practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Agwu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Agwu is board certified in pediatric infectious diseases by the American Board of Pediatrics. Dmand AI has Dr. Agwu's licenses on file in 2 states: Maryland and Ohio.

Dmand AI lists chronic hypertension among the conditions Dr. Agwu treats.

CMS data shows 16 Medicare services from Dr. Agwu across 1 procedure code in 2024, all of them office visits, for 15 Medicare patients. Medicare paid $913 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 15 Medicare patients who saw Dr. Agwu in 2024. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Agwu's median patient age at 39, with 12% women.

In 2024, Dr. Agwu wrote 267 Medicare Part D claims for 20 patients. 42% of them were for generic drugs. CMS names the drug for 122 of them, across 5 drugs with 11 or more claims each, at $261,634 in total drug cost. In 2023, CMS named 89 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Agwu for performance year 2024, reported as part of a group.

Dmand AI links 104 papers to Dr. Agwu, published from 2010 to 2025. 2017 was the busiest year, with 5. The most frequent topics are HIV Infections, Anti-HIV Agents and Viral Load. Dr. Agwu has published most often in J Acquir Immune Defic Syndr. Dr. Agwu's most frequent co-authors are Kelly Anne Gebo, MD, Aditya H. Gaur, MD and Baligh Ramzi Yehia, MD.

Dmand AI links Dr. Agwu to 6 clinical trials. Conditions studied include Acquired Immunodeficiency Syndrome, Slow Virus Diseases and HIV Infections. University of North Carolina, Chapel Hill sponsors the most, 2.

CMS Open Payments shows 103 general payments to Dr. Agwu from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 82% of the total. Gilead Sciences, Inc. paid the most, $36,127.

Dr. Agwu graduated from University of Maryland School of Medicine - Baltimore in 1999. Dr. Agwu is a member of AAP and IDSA.

Dr. Agwu is in network with 7 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.